Atlas FDA

Vysis CLL FISH Probe Kit

FDA premarket approval P150041/S003 · decided 2018-07-11

Approval details

PMA number
P150041
Supplement
S003
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Vysis CLL FISH Probe Kit
Generic name
Fluorescence in situ hybridization, chromosome 17p deletion (TP53)
Applicant
Abbott Molecular, Inc.
Date received
2018-06-15
Decision date
2018-07-11
Days to decision
26 days
Decision code
OK30
Product code
PNK
Advisory committee
Pathology
Expedited review
No
Location
Des Plaines, IL
Statement
Manufacturing process scale ranges.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Alinity m HCV (K252102)Abbott Molecular, Inc.2025-09-25
Alinity m EBV (09N43-095) (K243489)Abbott Molecular, Inc.2025-07-28
Alinity m CMV (K243485)Abbott Molecular, Inc.2025-07-01
Alinity m BKV (K241921)Abbott Molecular, Inc.2025-03-24
Alinity m Resp-4-Plex (K241573)Abbott Molecular, Inc.2025-02-14
Alinity m HSV 1 & 2 / VZV (K233349)Abbott Molecular, Inc.2024-05-03
Alinity m STI Assay (K222379)Abbott Molecular, Inc.2023-03-03
Alinity m EBV AMP Kit (List No. 09N43-095), Alinity m EBV CTRL Kit (List No. 09N43-085), Alinity m EBV CAL Kit (List No. 09N43-075) (K212778)Abbott Molecular, Inc.2022-07-15